Patent Assignment
Reel/Frame 065601/0347
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Recorded: 2023-11-16
Pages: 125
Assignor
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Executed: 2023-11-14
Assignees
MALLINCKRODT ENTERPRISES LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
SPECGX LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
OCERA THERAPEUTICS, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
STRATATECH CORPORATION
510 CHARMANY DR. NO. 169, MADISON, WISCONSIN, 53719
VTESSE LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN, IRELAND
SUCAMPO PHARMA AMERICAS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
Covered Properties
(486)
Anti-Constipation Composition
Patent:
6,414,016 →
Application:
09/655,760 →
Novel Composition and Method for Stabilizing the Same
Patent:
6,583,174 →
Application:
09/688,351 →
Rfi Canceller Using Narrowband and Wideband Noise Estimators
Skin Substitutes with Improved Barrier Function
Skin Substitutes for Irritancy Testing
Skin Substitutes and Uses Thereof
Method for Treating Drug-Induced Constipation
Carbon Monoxide Improves Outcomes in Tissue and Organ Transplants and Suppresses Apoptosis
Chloride Channel Opener
Preparation of Codeine from Morphine
Patent:
6,579,985 →
Application:
10/274,702 →
Dosage Unit Comprising a Prostaglandin Analog for Treating Constipation
Method and Apparatus for the Continuous Separation of Biological Fluids into Components
Novel Composition and Method for Stabilizing the Same
Valve with Smart Handle
Keratinocytes Expressing Exogenous Angiogenic Growth Factors
Preparation of Metal Mesoporphyrin Halide Compounds
Method and Apparatus for the Administration of Co
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Methylphenidate Solution and Associated Methods of Administration and Produciton
Stearate Composition and Method of Production Thereof
Enteric Coated Composition Comprising Prostaglandin Analogs as Chloride Channel Opener
Species Specific Dna Detection
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Method for Treating Abdominal Discomfort
Preparation of Metal Mesoporphyrin Compounds
Organotypically Cultured Skin Tissue Comprising Niks Cells That Express Exogenous Hif-1A
Human Skin Equivalents Expressing Exogenous Polypeptides
Skin Substitutes and Uses Thereof
Anti-Constipation Composition
Stearate Composition and Method
Method for Providing a Cathartic Effect
Method for Manufacturing Prostaglandin Analogue
Method for Treating Gastrointestinal Disorder
System and Method of Administering a Pharmaceutical Gas to a Patient
Skin Substitutes with Improved Barrier Function
Methods and compositions for selecting cells with increased potency
Method and Apparatus for Collecting a Blood Component and Performing a Photopheresis Treatment
Phototherapy Compositions and Methods
Chloride Channel Opener
Method and apparatus for generating nitric oxide for medical use
Human skin equivalents expressing exogenous polypeptides
Skin substitutes with improved purity
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Apparatus for the Continuous Separation of Biological Fluids into Components and Method of Using Same
Control System for Driving Fluids Through an Extracorporeal Blood Circuit
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Soft-Gelatin Capsule Formulation
Pharmaceutical Composition Comprising a Bi-Cyclic Compound and Method for Stabilizing the Bi-Cyclic Compound
Method for Preparing 15-Keto-Prostaglandin E Derivative
Method for Preparing Prostaglandin Derivative
Opiate Intermediates and Methods of Synthesis
Compositions Comprising Ornithine and Phenylacetate or Phenylbutyrate for Treating Hepatic Encephalopathy
Opiate Intermediates and Methods of Synthesis
Opiate Intermediates and Methods of Synthesis
Methods of Using Macrocyclic Agonists of the Ghrelin Receptor for Treatment of Gastrointestinal Motility Disorders
Method for Promoting Gastrointestinal Bicarbonate Secretion
High-Purity Large-Scale Preparation of Stannsoporfin
Matrix-Based Pulse Release Pharmaceutical Formulation
Process for Preparing Morphinan-6-One Products with Low Levels of Alpha, Beta-Unsaturated Ketone Compounds
Synthetic Route to 14-Hydroxyl Opiates Through 1-Halo-Thebaine or Analogs
Dye Compounds as Photoactive Agents
Preparation of Metal Mesoporphyrin Compounds
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
Novel Composition and Method for Stabilizing the Same
Use of Oripavine as a Starting Material For Buprenorphine
Skin Substitutes with Improved Barrier Function
Solid Support for Fmoc-Solid Phase Synthesis of Peptides
Reduced Dose Intravenous Acetaminophen
Composition and Method for the Release of Protected Peptides from a Resin
N-Demethylation of N-Methyl Morphinans
Sinomenine derivatives and processes for their synthesis
Process for the Preparation of Buprenorphine and Derivatives for Buprenorphine
Process and Compounds for the Production of (+)Opiates
Processes for the Preparation of Normorphinan Salts
Processes for the Production of (+)- "Nal" Morphinan Compounds
Kit for Species Specific Dna Detection
Process for the Preparation of 3-Hydroxymorphinan Derivatives
Keratinocytes Expressing Exogenous Angiogenic Growth Factors
System and Method of Administering a Pharmaceutical Gas to a Patient
Macrocyclic Antagonists of the Motilin Receptor for Treatment of Gastrointestinal Dysmotility Disorders
Preparation of Substituted Morphinan-6-Ones and Salts and Intermediates Thereof
Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates
Processes and Compounds for the Preparation of Normorphinans
Preparation of Amides from an Acid and Amine for Intermediates in the Synthesis of Morphinans
Preparation of 3,4-Dihydroisoquinolines in the Synthesis of Morphinans
Process for the Preparation of Hexahydroisoquinolines from 1,2,3,4-Tetrahydroisoquinolines
Process for the Preparation of 6-Beta Hydroxy Morphinan Compounds
Methods and Apparatus for the Administration of Co
Preparation of Tetrahydroisoquinolines from Dihydroisoquinolines
Preparation of 3,4-Dihydroisoquinolines from an Acid and an Amine
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Preparation of Oxymorphone from Oripavine
Substituted Berbines and Processes for their Synthesis
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Processes for the Synthesis of Five and Six Membered Heterocyclic Rings
Berberine Compounds and Processes for the Preparation of Berberine Compounds
Processes for the Synthesis of Opiates Alkaloids with Reduced Impurity Formation
Processes for Increasing the Yield of Opiate Alkaloid Derivatives
Processes for the Synthesis of Tertiary Amines
Processes for the Selective Amination of Ketomorphinans
Method of Purifying Crude Noscapine
Processes for the Alkylation of Norbuprenorphine with Reduced Impurity Formation
Processes for the Production of Buprenorphine with Reduced Impurity Formation
Recycling Process for Increasing the Yield of Opiate Alkaloid Derivatives
Processes for Synthesis of Opiate Alkaloid Derivatives
Novel Opiate Reduction Utilizing Catalytic Hydrogen Transfer Reaction
Crystalline and Amorphous Forms of Naltrexone Hydrochloride
Dried and Irradiated Skin Equivalents for Ready Use
Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates
Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates
Synthesis of Methylphenidate and Analogs Thereof
Crystalline Forms of Naltrexone Methobromide
Preparation of N-Alkylated Opiates by Reductive Amination
Human Skin Equivalents Expressing Exogenous Polypeptides
Process for the Reductive Alkylation of Normorphinans
(+)-Morphinanium Quaternary Salts and Processes for their Production
(+)-Morphinanium N-Oxides and Processes for their Production
(+)-6-Hydroxy-Morphinan or (+)-6-Amino-Morphinan Derivatives
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Preparation of Saturated Ketone Morphinan Compounds by Catalytic Isomerization
Preparation of Saturated Ketone Morphinan Compounds
Method for Preparing Prostaglandin Derivative
Method for Preparing Prostaglandin Derivative
Method for Preparing Prostaglandin Derivative
Solid Support for Fmoc-Solid Phase Synthesis of Peptide Acids
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Reductive Amination of 6-Keto Normorphinans by Catalytic Hydrogen Transfer
Preparation of 6-Alpha-Amino N-Substituted Morphinans by Catalytic Hydrogen Transfer
Method for the Enrichment of Buprenorphine Using Chromatographic Techniques
Methods of Reducing the Risk of Occurrence of Pulmonary Edema in Children in Need of Treatment with Inhaled Nitric Oxide
Methods of Reducing the Risk of Occurrence of Pulmonary Edema in Term or Near-Term Neonates in Need of Treatment with Inhaled Nitric Oxide
3-Oxy-Hydromorphone Derivatives
Preparation of Metal Mesoporphyrin Compounds
Preparation of 10-Keto Morphinans by Benzylic Oxidation
Method for Treating Damage Induced by an Anti-Tumor Agent, Treating Mucositis and Treating Tumor
Methods for Producing Hydrocodone, Hydromorphone or a Derivative Thereof
Heterogeneous Ruthenium Metal Catalyst for the Production of Hydrocodone, Hydromorphone or a Derivative Thereof
Method of Treatment Using Organotypically Cultured Skin Tissue Comprising Niks Cells That Express Exogenous Hif-1A
One-Pot Preparation of Hexahydroisoquinolines from Amides
One-Pot Preparation of Hexahydroisoquinolines from Dihydroisoquinolines
Method for Promoting Upper Gastrointestinal Bicarbonate Secretion
High-Purity Large-Scale Preparation of Stannsoporfin
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
Disposable Transdermal Patch Packaging
Apparatuses and Methods for Storing Pharmaceutical Product
Systems and Methods for Timing Dosage Periods
Systems and Methods for Manging Use of a Medicament
Container and Method for Facilitating Disposal of Unused Pharmaceutical Product
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Preparation of Saturated Ketone Morphinan Compounds Having Low Metal Content
Pen-Type Pharmaceutical Product Dispenser
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
Dosing Regimens and Methods of Treatment Using Carbon Monoxide
Powder Delivery Device
Pharmaceutical Composition Comprising a Bi-Cyclic Compound and Method for Stabilizing the Bi-Cyclic Compound
Method of Treatment Using Organotypically Cultured Skin Tissue Comprising Niks Cells That Express Exogenous Hif-1A
Tandem Process for Preparing N-Alkyl Morphinans
N-Demethylation of 6-Keto Morphinans
Soft-Gelatin Capsule Formulation
Pharmacutical Product Blister Pack Lockable Within Secondary Packaging
Process for the Preparation of Sufentanil Base and Related Compounds
Phototherapy Compositions and Methods
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Anti-Constipation Composition
Acth Prophylactic Treatment of Renal Disorders
Patent:
8,796,416 →
Application:
13/281,175 →
System And Method Of Administering A Pharmaceutical Gas To A Patient
System And Method Of Administering A Pharmaceutical Gas To A Patient
Novel Composition and Method for Stabilizing the Same
Patent:
8,097,649 →
Application:
13/289,386 →
Processes for Preparing Morphinan-6-One Products with Low Levels of Alpha Beta-Unsaturated Compounds
Diaza Heterocyclic Compounds for Phototherapy
Treatment of Tissue Adhesion
Dry Powder Fibrin Sealant
Dosage Unit Comprising a Prostaglandin Analog for Treating Constipation
Systems And Methods Of Administering A Pharmaceutical Gas to A Patient
Anti-Constipation Composition
Human Skin Equivalents Expressing Exogenous Polypeptides
Sinomenine Derivatives and Processes for their Synthesis
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Methods for Synthesizing Metal Mesoporphyrins
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Breathing Apparatus Detection and Purging
Reductive Amination of 6-Keto Morphinans by Catalytic Hydrogen Transfer
Gas Delivery Device and System
Compositions Comprising Ornithine and Phenylacetate or Phenylbutyrate for Treating Hepatic Encephalopathy
Gas Delivery Device and System
Dry Powder Fibrin Sealant
System And Method Of Administering A Pharmaceutical Gas To A Patient
Method for Preparing a Fatty Acid Derivative
Production of Alkaloids without the Isolation of Intermediates
Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
Dispensing System
Application:
13/657,711 →
Publication:
US 2014/0113970
Apparatus and Method for Monitoring Nitric Oxide Delivery
Nitric Oxide Delivery Device
Soft-Gelatin Capsule Formulation
Methods of Distributing a Pharmaceutical Product Comprising Nitric Oxide Gas for Inhalation
Methods for Treating Patients Who Are Candidates for Inhaled Nitric Oxide Treatment
Methods for Treating Hyperbilirubinemia with Stannsoporfin
Application:
13/691,677 →
Publication:
US 2013/0158362
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
One-Pot Preparation of Hexahydroisoquinolines from Amides
One Pot Process for Producing 6-Hydroxyl Nal-Opiate
System and Method of Administering a Pharmaceutical Gas to a Patient
Apparatus and Method for Monitoring Nitric Oxide Delivery
Use of Delta Tocopherol for the Treatment of Lysosomal Storage Disorders
Methods Of Administering High Concentrations Of Nitric Oxide
Immediate Release, Abuse Deterrent Pharmaceutical Compositions
Methods of Making L-Ornithine Phenyl Acetate
Container and Method for Facilitating Disposal of Unused Pharmaceutical Product
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Extended Release, Abuse Deterrent Pharmaceutical Compositions
System And Method Of Administering A Pharmaceutical Gas To A Patient
System and Method of Administering a Pharmaceutical Gas to a Patient
System And Method Of Administering A Pharmaceutical Gas To A Patient
Powder Delivery Device
High-Purity Large-Scale Preparation of Stannsoporfin
Clinical Decision Support System and Methods
(+)-6-Hydroxy-Morphinan or (+)-6-Amino-Morphinan Derivatives
Dried and Irradiated Skin Equivalents for Ready Use
Nitric Oxide Delivery Device
Gas Delivery Device and System
Gas Delivery Device and System
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
Administration And Monitoring Of Nitric Oxide In Ex Vivo Fluids
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Cannula for Minimizing Dilution of Dosing During Nitric Oxide Delivery
Suspicious Order Monitoring System and Method
Patent:
10,089,678 →
Application:
14/192,971 →
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Liposomal Cisplatin Compositions for Cancer Therapy
Cryopreservation of Viable Human Skin Substitutes
Abuse Deterrent Solid Dosage Form for Immediate Release with Functional Score
Therapeutic Gas Delivery Device with Pulsed and Continuous Flow Control
Acth for Treatment of Acute Respiratory Distress Syndrome
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Dried and Irradiated Skin Equivalents for Ready Use
Methods for Synthesizing Metal Mesoporphyrins
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Method And Apparatus For Generating Nitric Oxide For Medical Use
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Acth Prophylactic Treatment of Renal Disorders
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Compounds and Compositions for Use in Phototherapy and in Treatment of Ocular Neovascular Disease and Cancers
Methods of Reducing the Risk of Mortality Associated with a Medical Treatment
Application:
14/325,993 →
Publication:
US 2014/0377377
Nitric Oxide Delivery Device
Human Skin Equivalents Expressing Exogenous Polypeptides
Method and Apparatus for Disposal of a Pharmaceutical Product Blister Card
Application:
14/336,357 →
Publication:
US 2014/0331610
Breathing Apparatus Detection and Purging
Methods of Administering Nitric Oxide to Arterial or Arterialized Blood
Tocopherol and Tocopheryl Quinone Derivatives as Correctors of Lysosomal Storage Disorders
High-Purity Large-Scale Preparation of Stannsoporfin
Pharmaceutical Product Container with Permanent Locking Mechanism
PROCESS FOR THE PREPARATION OF RADIOIODINATED 3-FLUOROPROPYL-NOR-Beta-CIT
Substituted Berbines and Their Synthesis
Convenient Preparation of N-Substituted Morphinan-6-Ols from Morphinan-6-Ones
Production of 6-Hydroxy Morphinans Without the Isolation of Intermediates
Preparation of Normorphinans
Systems and Methods of Administering a Pharmaceutical Gas to a Patient
Process for the Preparation of Quaternary N-Alkyl Morphinan Alkaloid Salts
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Methods of Making L-Ornithine Phenyl Acetate
Systems And Methods For Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed To Nitric Oxide
Gas Delivery Device And System
Medicament Sachet Leak Testing System
Gas Delivery Device And System For Use In Magnetic Resonance Imaging
Dried and Irradiated Skin Equivalents for Ready Use
Systems And Method For Delivery Of Therapeutic Gas To Patients In Need Thereof Using Enhanced Breathing Circuit Gas (BCG) Flow Measurement
Systems And Method For Delivery Of Therapeutic Gas To Patients In Need Thereof Using Enhanced Breathing Circuit Gas (BCG) Flow Measurement
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Systems And Methods For Intelligent Gas Source Management
Enhanced Performance Verification Port For Therapeutic Gas Delivery
Systems and Methods for Delivery of Therapeutic Gas
Systems And Methods For Indicating Lifetime Of An NO2-to-NO Reactor Cartridge Used To Deliver NO For Inhalation Therapy To A Patient
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Sealable Secondary Packaging for Pharmaceutical Product Blister Pack
Spray Dried Compositions Having Different Dissolution Profiles and Processes for Their Preparation
Oxidative Dearomatization of Berbines
Systems And Methods For Manufacturing And Safety Of An NO2-to-NO Reactor Cartridge Used To Deliver NO For Inhalation Therapy To A Patient
Patent:
10,384,031 →
Application:
14/744,298 →
Abuse Deterrent Immediate Release Formulations Comprising Non-Cellulose Polysaccharides
High-Purity Large-Scale Preparation of Stannsoporfin
Process for Preparing Substituted Phenylalkanes
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
Breathing Apparatus Detection and Purging
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Methods for Synthesizing Metal Mesoporphyrins
Systems And Methods For Providing A Pulse Of A Therapeutic Gas With A Desired Flow Profile To Maximize Therapeutic Effectiveness
Method of Treating Patients with Hepatorenal Syndrome Type 1
Gas Delivery Device and System
Method and Apparatus for Generating Nitric Oxide for Medical Use
Systems And Methods for Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed to Nitric Oxide
Booster Valve for Pneumatic Circuits
Administration And Monitoring Of Nitric Oxide In Ex Vivo Fluids
Preparation of Sufentanil Citrate and Sufentanil Base
System And Method Of Administering A Pharmaceutical Gas To A Patient
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
Reduced Dose Intravenous Acetaminophen
Two-Step Process for Preparing 3-Substituted Phenylalkylamines
Nitric Oxide Delivery Device
Substituted Berbines and Processes for Their Synthesis
Use of Delta Tocopherol for the Treatment of Lysosomal Storage Disorders
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Centrifuge System and Method with Component Tracking
Patent:
10,434,239 →
Application:
15/261,968 →
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Device And Method For Diffusing High Concentration NO With Inhalation Therapy Gas
Systems And Methods for Compensating Long Term Sensitivity Drift Of Electrochemical Gas Sensors Exposed to Nitric Oxide
Method of Identifying and Treating Premature Infants at Risk for BPD
Recombinant Fibrinogen
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
Systems and Methods for Compensating Long Term Sensitivity Drift of Electrochemical Gas Sensors Exposed to Nitric Oxide
High-Purity Large-Scale Preparation of Stannsoporfin
Formulations of L-Ornithine Phenylacetate
Cold Storage of Organotypically Cultured Skin Equivalents for Clinical Applications
Dried and Irradiated Skin Equivalents for Ready Use
Acth Prophylactic Treatment of Renal Disorders
Biodegradable Extravascular Stent
Breathing Apparatus Detection and Purging
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Glucomannan Containing Pharmaceutical Compositions with Extended Release and Abuse Deterrent Properties
Use And Monitoring Of Inhaled Nitric Oxide With Left Ventricular Assist Devices
Extended Release, Abuse Deterrent Pharmaceutical Compositions
Compensating for Disruptions in Breathing Gas Flow Measurement
Compositions Comprising Ornithine and Phenylacetate or Phenylbutyrate for Treating Hepatic Encephalopathy
Method and Apparatus for the Manufacture of High Purity Carbon Monoxide
Reduced Dose Intravenous Acetaminophen
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Apparatus and Method for Humidity Conditioning Sample Gas of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Extended Release, Abuse Deterrent Dosage Forms
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Method for Collecting a Desired Blood Component and Performing a Photopheresis Treatment
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
Treatment of Diseases Associated with Hepatic Stellate Cell Activation Using Ammonia-Lowering Therapies
Systems and Methods for High Humidity Curing Within Tablet Coating System
Support for Centrifuge Tubing
Methods for Synthesizing Metal Mesoporphyrins
Application:
15/603,654 →
Publication:
US 2017/0260217
Tocopherol and Tocopheryl Quinone Derivatives as Correctors of Lysosomal Storage Disorders
Fibrinogen Preparations Enriched in Fibrinogen with an Extended Alpha Chain
Cyclodextrin for the Treatment of Lysosomal Storage Diseases
Combinational Liposome Compositions for Cancer Therapy
Apparatus and Method for Monitoring Nitric Oxide Delivery
Processes For Preparing Morphinan-6-One Products With Low Levels Of Alpha, Beta-Unsaturated Ketone Compounds
Application:
15/710,990 →
Publication:
US 2018/0008596
Immediate Release, Abuse Deterrent Pharmaceutical Compositions
Application:
15/714,137 →
Publication:
US 2018/0008532
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Treatment and Prevention of Muscle Loss Using L-Ornithine in Combination with at Least One of Phenylacetate and Phenylbutyrate
Treatment and Prevention of Neuronal Cell Loss Using L-Ornithine in Combination with at Least One of Phenylacetate and Phenylbutyrate
Application:
15/751,442 →
Publication:
US 2020/0206174
Cannula for Minimizing Dilution of Dosing During Nitric Oxide Delivery
Pharmaceutical Combination of Opioid and Prostaglandin Compound
Treatment of Portal Hypertension and Restoration of Liver Function Using L-Ornithine Phenylacetate
Methods of Reducing the Risk of Mortality Associated With a Medical Treatment
High-Purity Large-Scale Preparation of Stannsoporfin
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
Reduced Dose Intravenous Acetaminophen
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Abuse Deterrent Immediate Release Formulations Comprising Non-Cellulose Polysaccharides
Delayed Sustained Release Pharmaceutical Compositions
Treatment of Diseases Associated with Hepatic Stellate Cell Activation Using Ammonia-Lowering Therapies
Liposomal Cisplatin Compositions for Cancer Therapy
Human Skin Equivalents Expressing Exogenous Polypeptides
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Use and Monitoring of Inhaled Nitric Oxide with Left Ventricular Assist Devices
Methods to Improve Organ Viability
Cryopreservation of Viable Human Skin Substitutes
Methods for Synthesizing Metal Mesoporphyrins
Use of Human Skin Substitutes Expressing Exogenous Il-12 to Treat a Wound Bed
System And Method Of Administering A Pharmaceutical Gas To A Patient
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Processing Blood
Processing Blood
Process for Preparing Acylated Amphetamine Derivatives
Systems and Methods for Intelligent Gas Source Management and/or Systems and Methods for Delivery of Therapeutic Gas and/or Enhanced Performance Verification for Therapeutic Gas Delivery
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Gas Delivery Device and System for Use in Magnetic Resonance Imaging
One Step Milling Process for Preparing Micronized Paliperidone Esters
Application:
16/219,253 →
Publication:
US 2019/0183896
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
Systems and Method for Delivery of Therapeutic Gas to Patients in Need Thereof Using Enhanced Breathing Circuit Gas (Bcg) Flow Measurement
Preparation of Sufentanil Citrate and Sufentanil Base
High-Purity Large-Scale Preparation of Stannsoporfin
Multilayer Beads for Pharmaceutical Use
Liquid Medicine Injection Device
Devices and Methods for Monitoring Oxygenation Uring Treatment with Delivery of Nitric Oxide
Application:
16/365,263 →
Publication:
US 2019/0216377
Methods of Administering Inhaled Nitric Oxide Gas
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/411,944 →
Publication:
US 2019/0328831
Tissue Container Systems
Systems and Methods for Manufacturing and Safety of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Therapeutic Gas Delivery Device With Pulsed And Continuous Flow Control
Methods for Treating Hyperbilirubinemia with Stannsoporfin
Application:
16/505,295 →
Publication:
US 2020/0016167
Centrifuge System and Method with Component Tracking
Patent:
11,020,522 →
Application:
16/537,103 →
Apparatus and Method for Monitoring Nitric Oxide Delivery
Systems and Methods for High Humidity Curing Within Tablet Coating System
Abuse Deterrent Immediate Release Capsule Dosage Forms
Extended Release, Abuse Deterrent Pharmaceutical Compositions
Processes of Making L-Ornithine Phenylacetate
Apparatus and Method for Humidity Conditioning Sample Gas of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Clinical Decision Support System and Methods
Systems and Methods for Indicating Lifetime of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Enhanced Performance Verification Port for Therapeutic Gas Delivery
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Systems and Methods for Delivery of Therapeutic Gas
L-Ornithine Phenyl Acetate and Methods of Making Thereof
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
System And Method Of Administering A Pharmaceutical Gas To A Patient
Application:
16/779,912 →
Publication:
US 2020/0163989
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Methods Of Administering High Concentrations Of Nitric Oxide
Method of Identifying and Treating Premature Infants at Risk for Bpd
Extended Release, Abuse Deterrent Dosage Forms
Intelligent Gas Source Management
Systems and Methods for Intelligent Gas Source Management
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/828,674 →
Publication:
US 2020/0246418
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
16/828,681 →
Publication:
US 2020/0237856
Administration and Monitoring of Nitric Oxide in Ex Vivo Fluids
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
High-Purity Large-Scale Preparation of Stannsoporfin
Methods to Increase Functional Capacity and Quality of Life in Bronchietasis Patients with Nontuberculous Mycobacteria
Application:
16/875,000 →
Publication:
US 2020/0360648
Devices, Methods, and Systems for Priming, Separating, and Collecting Blood Components
Abuse Deterrent Immediate Release Formulations Comprising Non-Cellulose Polysaccharides
Systems And Methods For Providing A Pulse Of A Therapeutic Gas With A Desired Flow Profile To Maximize Therapeutic Effectiveness
Application:
17/007,603 →
Publication:
US 2020/0398019
Systems and Method for Delivery of Therapeutic Gas to Patients, in Need Thereof, Receiving Breathing Gas from a Ventilator That Varies at Least Pressure and/or Flow Using Enhanced Therapeutic Gas (No) Flow Measurement
Method of Treating Patients with Hepatorenal Syndrome Type 1 and Low Mean Arterial Pressure
Application:
17/083,409 →
Publication:
US 2021/0128676
Preparation of Sufentanil Citrate and Sufentanil Base
Application:
17/091,109 →
Publication:
US 2021/0061793
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
17/104,864 →
Human Skin Equivalents Expressing Exogenous Polypeptides
Application:
17/141,945 →
Publication:
US 2021/0146012
Device And Method For Diffusing High Concentration NO With Inhalation Therapy Gas
Application:
17/151,410 →
Publication:
US 2021/0138178
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Application:
17/175,779 →
Publication:
US 2021/0260327
Processing Blood
Methods of Modulating Pericytes
Patent:
11,752,199 →
Application:
17/185,586 →
Systems And Methods Of Administering A Pharmaceutical Gas To A Patient
Application:
17/215,686 →
Publication:
US 2021/0213235
Gas Sensor Module
Viable Bioengineered Skin Constructs
Application:
17/319,760 →
Publication:
US 2021/0355451
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
17/340,765 →
Publication:
US 2021/0290725
Use and Monitoring of Inhaled Nitric Oxide with Left Ventricular Assist Devices
Methods to Improve Organ Viability
Methods of Modulating Corticosteroid Response
Application:
17/362,497 →
Publication:
US 2021/0322520
Systems and Methods for High Humidity Curing Within Tablet Coating System
Methods of Promoting Remyelination
Application:
17/420,622 →
Publication:
US 2022/0111012
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
Application:
17/458,202 →
Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells
Application:
17/458,206 →
Publication:
US 2021/0388318
Devices And Methods For Engaging Indexed Valve And Pressurized Canister Assembly With Collar And For Linear Actuation By Plunger Assembly Into Fluid Communication With Device For Regulating Drug Delivery
Application:
17/509,556 →
Publication:
US 2022/0040438
Method for Ex-Vivo Expansion of Regulatory T Cells with Enhanced Suppressive Function for Clinical Application in Immune Mediated Diseases
Application:
17/515,985 →
Publication:
US 2022/0056410
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Enhanced Performance Verification Port for Therapeutic Gas Delivery
Formulations of L-Ornithine Phenylacetate
Application:
17/559,453 →
Publication:
US 2022/0184014
Formulations of L-Ornithine Phenylacetate
Application:
17/570,253 →
Publication:
US 2022/0202755
Method of Treating Patients with Hepatorenal Syndrome Type 1
Application:
17/587,442 →
Publication:
US 2022/0143132
Gas Delivery System
Application:
17/598,058 →
Publication:
US 2022/0184293
Methods of Assessing Hepatic Encephalopathy
Apparatus and Method for Filtering Liquid Particles from Inspiratory Gas Flow of a Patient Breathing Circuit Affiliated with a Ventilator and/or Nitric Oxide Delivery System
Intelligent Gas Source Management
Methods for Treating Acute Wounds and Improving Outcomes
Application:
17/763,552 →
Publication:
US 2022/0347353
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application:
17/767,009 →
Publication:
US 2022/0362192
Medical Instrument
Patent:
628,692 →
Application:
29/339,045 →
Medical Powder Delivery Instrument
Patent:
683,851 →
Application:
29/394,931 →
Therapeutic Gas Delivery Device
Patent:
701,963 →
Application:
29/455,842 →
Therapeutic Gas Delivery Device
Patent:
729,936 →
Application:
29/464,499 →
Therapeutic Gas Delivery Device
Patent:
730,525 →
Application:
29/467,025 →
Therapeutic Gas Delivery Device
Patent:
729,937 →
Application:
29/467,028 →
MRI Compatible Therapeutic Gas Injector Module
Patent:
776,278 →
Application:
29/544,067 →
MRI Compatible Therapeutic Gas Delivery Cart
Patent:
776,279 →
Application:
29/544,072 →
MRI Compatible Therapeutic Gas Injector Module
Patent:
797,935 →
Application:
29/578,294 →
MRI Compatible Therapeutic Gas Delivery Cart
Patent:
807,510 →
Application:
29/578,295 →
MRI Compatible Therapeutic Gas Injector Module
Patent:
823,472 →
Application:
29/614,133 →
Methods for Treating Acute Wounds and Improving Outcomes
Application:
62/979,649 →
Bioengineered Human Skin Construct
Application:
63/024,258 →
Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application:
63/028,874 →
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application:
63/034,602 →
Engineered Skin Construct Overlay of Autograft
Application:
63/049,447 →
Methods of Modulating Corticosteroid Response
Application:
63/083,532 →
Allogeneic Cultured Keratinocyte Products
Application:
63/194,672 →
Tissue Container Systems
Application:
63/194,682 →
Methods for Priming Allogeneic Cultured Keratinocyte Compositions for Topical Use
Application:
63/194,687 →
Stratagraft® Secretes Soluble Factors Associated with Regenerative Wound Healing
Application:
63/208,309 →
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome
Application:
63/222,092 →
Allogeneic Cultured Keratinocyte Products
Application:
63/224,706 →
Allogeneic Cultured Keratinocyte Products
Application:
63/227,119 →
Pre-Filled Manual Injector Apparatus
Application:
63/238,543 →
Injectable Sustained Release Pharmaceutical Composition
Application:
63/282,014 →
Methods of Extracorporeal Photopheresis for Immune-Related Adverse Events
Application:
63/304,937 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Grant of Security Interest in Patents
Sep 16, 2016
From: STRATATECH CORPORATION
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 040059/0222 →
Assignment of Assignor's Interest
Dec 13, 2017
From: MALLINCKRODT LLC
To: SPECGX LLC
Reel/Frame 044891/0376 →
Nunc Pro Tunc Assignment
May 24, 2019
From: INFACARE PHARMACEUTICAL CORPORATION
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049274/0943 →
Nunc Pro Tunc Assignment
May 24, 2019
From: MALLINCKRODT IP UNLIMITED COMPANY
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049274/0983 →
Nunc Pro Tunc Assignment
May 24, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP UNLIMITED COMPANY
Reel/Frame 049274/0954 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 049643/0168 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 049643/0397 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT PHARMA IP TRADING D.A.C.
To: MALLINCKRODT IP
Reel/Frame 049643/0348 →
Nunc Pro Tunc Assignment
Jul 1, 2019
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 049643/0282 →
Notice of Grant of Security Interest in Intellectual Property
Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Conversion
Jan 22, 2020
From: SUCAMPO AG
To: SUCAMPO GMBH
Reel/Frame 051666/0768 →
Conversion
Jan 27, 2020
From: SUCAMPO AG
To: SUCAMPO GMBH
Reel/Frame 051708/0596 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 049822, Frame 0674
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0454 →
Release of Patent Security Interests Recorded at Reel 032480, Frame 0001
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH
Reel/Frame 065609/0322 →
Release of Patent Security Interests Recorded at Reel 044173, Frame 0574
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0128 →
Release of Patent Security Interests Recorded at Reel 040059, Frame 0222
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0083 →
Release of Patent Security Interests Recorded at Reel 035454, Frame 0768
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0035 →
Release of Patent Security Interests Recorded at Reel 036662, Frame 0053
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0503 →
Release of Security Interests
Dec 3, 2024
From: ACQUIOM AGENCY SERVICES, LLC, AS COLLATERAL AGENT
To: MALLINCKRODT PHARMA IP TRADING LIMITED; STRATATECH CORPORATION; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 069476/0103 →